• Preventative Care in Patients With Cirrhosis
  Elliot B. Tapper, MD
  Summarize the key points on preventative care in cirrhosis, utilizing the recent ACG Guideline.
• Acute Liver Failure: Rapid Response, Refined Strategies
  Lafaine Grant, MD
  Examine the best practices in the risk stratification and management of acute liver failure, focusing on updates since the 2023 ACG Guideline.
• MASLD in Motion: Emerging Therapies and Targets
  Mary E. Rinella, MD, FACG
  Review recent data and promising medical therapies for MASLD.
• Medical Homes and ALD: A New Model for a Complex Disease
  Hanna Blaney, MD, MPH
  Identify best practices in treating EtOH-related liver disease, focusing on medical home-based approaches.
• Panel Q & A

• Pregnancy and IBD: Balancing Safety and Science
  Uma Mahadevan, MD, FACG
  Assess the risks and benefits of IBD medications in the management of IBD in pregnancy, and review the most recent ACG guidelines.
• Therapy Positioning in Crohn’s: Guidelines Meet Clinical Judgment
  Edward V. Loftus, Jr., MD, FACG
  Review drug positioning vis-à-vis Crohn’s disease risk stratification and the 2025 ACG guidelines.
• UC Therapy: Positioning for Better Outcomes
  Millie D. Long, MD, MPH, FACG
  Review drug positioning vis-à-vis ulcerative colitis risk stratification and the 2025 ACG guidelines.
• Managing Acute Severe UC: Speed, Strategy, and Steroid-Free Goals
  Shrinivas Bishu, MD, FACG
  Review best practices in UC management, focusing on managing ASUC in the context of the ACG guidelines.
• Artificial Intelligence in IBD: A Practical Primer for GIs
  Ryan W. Stidham, MD
  Discuss AI applications in IBD care, including endoscopic scoring, and how that could help standardize IBD care in general GI settings.
• Panel Q & A

Sunday Optional Learning Luncheon Bonus Sessions

13. Chronic Constipation: It Is More Than Just the Push
    Kyle D. Staller, MD, MPH
    Identify and differentiate common causes of chronic constipation and address why laxative therapies are ineffective in many cases.
14. Diverticulosis, Itis, SUDD, SCAD: Please Help Me Make Sense Out of This Alphabet Soup
    Lisa L. Strate, MD, MPH, FACG
    Define and differentiate from among diverticulosis, complicated vs uncomplicated diverticulitis, symptomatic uncomplicated diverticular disease, and segmental colitis associated with diverticulosis, and address when antibiotics and surgical interventions should be considered.
15. The Role of Personalized and Web/App-Based Brain-Gut Behavioral Therapies: Selecting the Right Patient for the Right Intervention
    Madison Simons, PsyD
    Assess the evidence for the use of BGBT/digital therapeutics for GI disorders and address the pros and cons of different strategies (CBT, GDH, mindful medication in individual, group, or app-based settings).
16. Risk Stratification and Management of Post-Operative Crohn’s Disease
    Benjamin L. Cohen, MD
    Review the risk stratification and management of post-operative Crohn’s, including endoscopic scoring and rational approach to post-operative disease surveillance.
17. Fecal Incontinence: Please Don’t Leak the Secret
    Leila Neshatian, MD, MSc
    Discuss the quality-of-life impact and epidemiology of fecal incontinence, and how to identify and treat the common causes.
18. A Pragmatic Approach to the Medical and Surgical Management of Perianal Crohn’s Disease
    Kathryn E. Hutchins, MD, FACG
    Integrate best practices to diagnose and manage perianal Crohn’s, focusing on medical therapies (when to switch biologics, response assessment), and surgical approaches (fistulotomies and setons).
19. Geriatric GI: What's Old and What's New?
    Adam S. Faye, MD, MS
    Discuss significant changes which occur in the GI tract as we age and pragmatic methods of treatment in a population with limited evidence-based analysis.
20. Medical Management of Obesity for the Clinical Gastroenterologist
    Octavia Pickett-Blakely, MD, MHS
    Review the medical management of obesity from the perspective of a clinical gastroenterologist.
21. Perioperative Risk Assessment and Management of Patients With Cirrhosis
    Nadim Mahmud, MD, MPH
    Review the ACG guidelines on perioperative risk assessment and management of patients with cirrhosis.
22. Endoscopic Management of Ectopic and Gastric Varices
    Allison R. Schulman, MD, MPH, FACG
    Describe novel endoscopic approaches to treating ectopic and gastric varices, focusing on methods such as EUS-guided coiling.
23. Is Food the Cause and the Cure? Can Dietary Manipulation Truly Treat All Gastrointestinal Ills?
    William D. Chey, MD, MACG
    Recognize the role food plays in the pathophysiology of common GI disorders and implement the best dietary strategies for symptom improvement.
24. Nausea and Vomiting: Where Is a Gastroenterologist to Start?
    Thangam Venkatesan, MD
    Summarize common and rare gastrointestinal causes of nausea and vomiting, and discuss clues which may suggest that these symptoms are emanating from outside the GI tract.

Symposium E: Beyond the Scope – Advances in Bariatric Endoscopy, Biliary Drainage, and Pancreatitis Care [LIVESTREAM]
Moderator: Pichamol Jirapinyo, MD, MPH, FACG

• Updates on Bariatric Endoscopy
  Pichamol Jirapinyo, MD, MPH, FACG
  Review new data in bariatric endoscopy, focusing on new devices and long-term efficacy data.
• Biliary Drainage: Tips, Tricks, and New Approaches
  Mohammad Bilal, MD, FACG
  Review new approaches to biliary drainage, focusing on EUS vs ERCP-guided drainage, and touching on more advanced techniques.
• Pain Management of Chronic Pancreatitis: When and How to Manage With Medications, Plexus Blocks, and Surgeries
  Jorge D. Machicado, MD
  Identify the best approaches to managing pain in chronic pancreatitis, focusing on patient selection for medications vs plexus blocks vs pancreatectomy.
• Panel Q & A

Symposium F: GI Vagaries and Conundrums
Moderator: Brian E. Lacy, MD, PhD, FACG

• Are My Symptoms Due to a Food Allergy or Sensitivity?
  Brian E. Lacy, MD, PhD, FACG
  Define food allergies vs sensitivities, discuss whether GI symptoms are truly due to food allergies/sensitivities, and address the accuracy of current testing (e.g., disaccharidase assays, skin prick/patch, IgE serologies, confocal laser endomicroscopy, and specific IBS food tests).
• Are Mast Cells Really the Cause of My Symptoms?
  Matthew J. Hamilton, MD
  Define the role of mast cells in the development of mast cell activation syndrome, systemic mastocytosis, hereditary alpha tryptasemia, and other GI disorders.
• Common Gastrointestinal Disorders Associated With Hypermobility Syndromes
  Lucinda A. Harris, MD, MS, MACG
  Address the types and prevalence of GI illnesses in individuals with hypermobility syndromes and how best to treat these disorders.
• Panel Q & A

Symposium G: GI Bleeding Unplugged: Real-World Tools and Techniques [LIVESTREAM]
Moderator: Andy Tau, MD

• Endoscopic Approaches for Non-Variceal Upper GI Bleeding
  Andy Tau, MD
  Assess new approaches and tools to treat GI bleeds, including polymers and over-the-scope clips.
• Diagnosis and Management of Small Bowel Bleeding
  Shabana F. Pasha, MD, FACG
  Implement best practices for the diagnosis and endoscopic and medical management of small bowel bleeding.
• Management of Acute Lower GI Bleeding
  Neil Sengupta, MD, FACG
  Review updates on the risk stratification and medical, interventional radiologic, and endoscopic approaches for the management of lower GI bleeding.
• Panel Q & A

Symposium H: Immune-Mediated Gut Disorders: From Celiac to Checkpoints
Moderator: Amy S. Oxentenko, MD, MACG

• How to Diagnose and Manage Celiac Disease: What’s the Latest?
  Amy S. Oxentenko, MD, MACG
  Review the diagnosis and management of celiac disease, focusing on comparative utility of serologic vs histologic diagnosis and treatment.
• Microscopic Colitis: Practical Pearls for Everyday Practice
  Kristin E. Burke, MD, MPH
  Outline tips and tricks to manage uncomplicated and refractory autoimmune enteropathy.
• Immune Checkpoint Inhibitor and CAR-T Cell Enteritis and Colitis
  Stephen B. Hanauer, MD, MACG
  Apply best practices for managing immunotherapy-related GI inflammation including managing anti-inflammatory therapy in the setting of active malignancy.
• Panel Q & A